MX2008010806A - Sistema para la administracion de ciclosporina nebulizada y metodos de tratamiento. - Google Patents

Sistema para la administracion de ciclosporina nebulizada y metodos de tratamiento.

Info

Publication number
MX2008010806A
MX2008010806A MX2008010806A MX2008010806A MX2008010806A MX 2008010806 A MX2008010806 A MX 2008010806A MX 2008010806 A MX2008010806 A MX 2008010806A MX 2008010806 A MX2008010806 A MX 2008010806A MX 2008010806 A MX2008010806 A MX 2008010806A
Authority
MX
Mexico
Prior art keywords
cyclosporine
filter
treatment
methods
trap
Prior art date
Application number
MX2008010806A
Other languages
English (en)
Inventor
Johnny Lai
Original Assignee
Novartis Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Ag filed Critical Novartis Pharma Ag
Publication of MX2008010806A publication Critical patent/MX2008010806A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/105—Filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0087—Environmental safety or protection means, e.g. preventing explosion
    • A61M16/009—Removing used or expired gases or anaesthetic vapours
    • A61M16/0093—Removing used or expired gases or anaesthetic vapours by adsorption, absorption or filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/105—Filters
    • A61M16/106—Filters in a path
    • A61M16/1065—Filters in a path in the expiratory path
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental & Geological Engineering (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Ecology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a sistemas que comprenden un dispositivo de distribución presurizado y una formulación de ciclosporina acoplada a un filtro de exhalación o trampa, que es capaz de prevenir que la ciclosporina se escape hacia el ambiente local. Un aparato para utilizarse en el sistema, comprende ya sea un filtro de exhalación y un dispositivo de distribución presurizado, en donde el filtro de exhalación es capaz de proporcionar una alta eficiencia de filtrado y mantener una baja resistencia al filtrado después de utilizarse con la formulación, o bien, una trampa que proporciona un medio para que el gas expirado sea liberado en una cámara de disolvente que contiene un disolvente con alta afinidad por la cictosporina. Estos sistemas se pueden emplear para el tratamiento de pacientes con trastornos pulmonares, pacientes con transplante de órganos, tales como pacientes con transplante pulmonar, y otros trastornos relacionados con el sistema inmunitario.
MX2008010806A 2006-02-22 2007-02-22 Sistema para la administracion de ciclosporina nebulizada y metodos de tratamiento. MX2008010806A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77591906P 2006-02-22 2006-02-22
PCT/US2007/004861 WO2007100741A2 (en) 2006-02-22 2007-02-22 System for delivering nebulized cyclosporine and methods of treatment

Publications (1)

Publication Number Publication Date
MX2008010806A true MX2008010806A (es) 2008-09-01

Family

ID=38235470

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008010806A MX2008010806A (es) 2006-02-22 2007-02-22 Sistema para la administracion de ciclosporina nebulizada y metodos de tratamiento.

Country Status (11)

Country Link
US (1) US20100163021A1 (es)
EP (1) EP1988956A2 (es)
JP (1) JP2009527335A (es)
KR (1) KR20080108997A (es)
CN (1) CN101389370A (es)
AU (1) AU2007221196B2 (es)
BR (1) BRPI0710074A2 (es)
CA (1) CA2642656A1 (es)
MX (1) MX2008010806A (es)
RU (1) RU2442616C2 (es)
WO (1) WO2007100741A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2538357T3 (es) 2005-04-11 2015-06-19 Crealta Pharmaceuticals Llc Formas variantes de urato oxidasa y uso de las mismas
AU2010226442A1 (en) * 2009-03-20 2011-10-13 Antares Pharma, Inc. Hazardous agent injection system
US9377454B2 (en) 2009-06-25 2016-06-28 Crealta Pharmaceuticals Llc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US8689439B2 (en) 2010-08-06 2014-04-08 Abbott Laboratories Method for forming a tube for use with a pump delivery system
US8377001B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Feeding set for a peristaltic pump system
US8377000B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Enteral feeding apparatus having a feeding set
US10052224B1 (en) * 2013-10-21 2018-08-21 IngMar Medical, Ltd. Snore module
CN105987724A (zh) * 2015-02-26 2016-10-05 顺力西科技股份有限公司 用于呼吸器的测试治具
US20200237881A1 (en) * 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
DE102018212411A1 (de) * 2018-07-25 2020-01-30 Robert Bosch Gmbh Verfahren zur Gewinnung einer Atemprobe eines Probanden und Vorrichtung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824451A (en) * 1985-12-31 1989-04-25 Kimberly-Clark Corporation Melt-blown filter medium
GB9120013D0 (en) * 1991-09-19 1991-11-06 Wellcome Found Method and apparatus for administering respirable pharmaceutical particles
US6041777A (en) * 1995-12-01 2000-03-28 Alliance Pharmaceutical Corp. Methods and apparatus for closed-circuit ventilation therapy
US20020006901A1 (en) * 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
AUPQ656200A0 (en) * 2000-03-29 2000-04-20 Novapharm Research (Australia) Pty Ltd Chemical upgrading of filters
US20040147433A1 (en) * 2001-06-14 2004-07-29 Marcus Keep Neuroimmunophilins for selective neuronal radioprotection
US20050129718A1 (en) * 2001-12-20 2005-06-16 Sherman Bernard C. Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
US6776824B2 (en) * 2002-01-11 2004-08-17 Sheree H. Wen Antiviral and antibacterial filtration module for a vacuum cleaner or other appliance

Also Published As

Publication number Publication date
WO2007100741A2 (en) 2007-09-07
AU2007221196A1 (en) 2007-09-07
AU2007221196B2 (en) 2011-08-04
KR20080108997A (ko) 2008-12-16
EP1988956A2 (en) 2008-11-12
RU2008137532A (ru) 2010-03-27
CN101389370A (zh) 2009-03-18
WO2007100741A3 (en) 2007-12-27
US20100163021A1 (en) 2010-07-01
CA2642656A1 (en) 2007-09-07
JP2009527335A (ja) 2009-07-30
RU2442616C2 (ru) 2012-02-20
BRPI0710074A2 (pt) 2011-08-02

Similar Documents

Publication Publication Date Title
MX2008010806A (es) Sistema para la administracion de ciclosporina nebulizada y metodos de tratamiento.
NZ611759A (en) Humidification system
TN2009000162A1 (en) Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
MX2008010222A (es) Antibioticos nebulizados para terapia de inhalacion.
MX2007008379A (es) Metodos y composiciones para minimizar la acumulacion de insulina inhlable en los pulmones.
EP4289462A3 (en) Apparatus for use in a respiratory support system
WO2007015966A3 (en) Apparatus and method for administering a therapeutic agent into tissue
EP2772148A3 (en) Method and system for vaporization of a substance
WO2010102000A8 (en) High concentration no2 generating system and method for generating high concentration no2 using the generating system
EP1971288A4 (en) MICRONIZED DEVICE FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES AND METHOD OF USE
WO2010093861A3 (en) System, method and device for tissue-based diagnosis
EP2139428A4 (en) Cell separation device and method for its use
EP2636319A3 (en) Smoke filters for smoking devices with porous masses having a carbon particle loading and an encapsulated pressure drop
EA201390049A1 (ru) Сухой порошковый препарат, содержащий ингибитор фосфодиэстеразы
WO2006127007A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
DE602006014821D1 (de) Ex-vivo-verfahren zur genzuführung
WO2007137204A3 (en) Methods for the delivery of a beta2 agonist to induce bronchodilation and formulations for use in the same
WO2008151235A3 (en) Compositions for delivering medicaments into the lungs, uses thereof
WO2012037380A3 (en) Formulations of guanylate cyclase c agonists and methods of use
WO2010011329A3 (en) The delivery of powdered drug via inhalation
WO2005072217A3 (en) Anesthetic agent recovery
UA96290C2 (ru) Новый способ оценивания защиты средством индивидуальной защиты дыхательного тракта от биологических веществ
Santos et al. Effects of oleanolic acid on pulmonary morphofunctional and biochemical variables in experimental acute lung injury
WO2005041921A3 (en) Dry powder compositions for inhalation therapy comprising calcium stearate, medical devices therefor
EA201101300A1 (ru) Способ или система на основе биомаркеров, предназначенная для мониторинга лечения

Legal Events

Date Code Title Description
FA Abandonment or withdrawal